4//SEC Filing
Wang Theodore T 4
Accession 0001760460-21-000002
CIK 0001600132other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 12:39 PM ET
Size
16.5 KB
Accession
0001760460-21-000002
Insider Transaction Report
Form 4
Puissance Capital Fund (GP) LLC
10% Owner
Transactions
- Award
Common Stock
2021-04-26$4.00/sh+609,231$2,436,924→ 1,763,077 total - Award
Warrants (Right to buy)
2021-04-26+380,950→ 380,950 totalExercise: $12.00From: 2016-11-29Exp: 2023-11-29→ Common Stock (380,950 underlying) - Award
Warrants (Right to buy)
2021-04-26+304,286→ 685,236 totalExercise: $18.63From: 2018-03-29Exp: 2022-09-29→ Common Stock (304,286 underlying)
Puissance Capital Management LP
10% Owner
Transactions
- Award
Warrants (Right to buy)
2021-04-26+304,286→ 685,236 totalExercise: $18.63From: 2018-03-29Exp: 2022-09-29→ Common Stock (304,286 underlying) - Award
Warrants (Right to buy)
2021-04-26+380,950→ 380,950 totalExercise: $12.00From: 2016-11-29Exp: 2023-11-29→ Common Stock (380,950 underlying) - Award
Common Stock
2021-04-26$4.00/sh+609,231$2,436,924→ 1,763,077 total
Wang Theodore T
Director10% Owner
Transactions
- Award
Warrants (Right to buy)
2021-04-26+380,950→ 380,950 totalExercise: $12.00From: 2016-11-29Exp: 2023-11-29→ Common Stock (380,950 underlying) - Award
Common Stock
2021-04-26$4.00/sh+609,231$2,436,924→ 1,763,077 total - Award
Warrants (Right to buy)
2021-04-26+304,286→ 685,236 totalExercise: $18.63From: 2018-03-29Exp: 2022-09-29→ Common Stock (304,286 underlying)
Transactions
- Award
Warrants (Right to buy)
2021-04-26+380,950→ 380,950 totalExercise: $12.00From: 2016-11-29Exp: 2023-11-29→ Common Stock (380,950 underlying) - Award
Common Stock
2021-04-26$4.00/sh+609,231$2,436,924→ 1,763,077 total - Award
Warrants (Right to buy)
2021-04-26+304,286→ 685,236 totalExercise: $18.63From: 2018-03-29Exp: 2022-09-29→ Common Stock (304,286 underlying)
Transactions
- Award
Warrants (Right to buy)
2021-04-26+304,286→ 685,236 totalExercise: $18.63From: 2018-03-29Exp: 2022-09-29→ Common Stock (304,286 underlying) - Award
Common Stock
2021-04-26$4.00/sh+609,231$2,436,924→ 1,763,077 total - Award
Warrants (Right to buy)
2021-04-26+380,950→ 380,950 totalExercise: $12.00From: 2016-11-29Exp: 2023-11-29→ Common Stock (380,950 underlying)
Footnotes (1)
- [F1]These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001694061
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 12:39 PM ET
- Size
- 16.5 KB